Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Hemangioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03474614
What this trial is testing

Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation

Who this might be right for
Cerebral Cavernous Malformations
St. Joseph's Hospital and Medical Center, Phoenix 4
Testing effectiveness (Phase 2)Study completedNCT04947124
What this trial is testing

Determine the Safety and Tolerability of 2 Concentrations of QLS-101

Who this might be right for
Sturge-Weber Syndrome (SWS)GlaucomaGlaucoma Congenital+1 more
Qlaris Bio, Inc. 3
Not applicableLooking for participantsNCT05484245
What this trial is testing

Sonography-guided Resection of Brain Mass Lesions

Who this might be right for
Tumor, BrainArteriovenous MalformationsCavernoma+1 more
Sklifosovsky Institute of Emergency Care 100
Testing effectiveness (Phase 2)Study completedNCT03589014
What this trial is testing

Treat_CCM: Propranolol in Familial Cerebral Cavernous Malformation

Who this might be right for
Cerebral Cavernous Malformation
Mario Negri Institute for Pharmacological Research 71
Very early researchEnded earlyNCT01764451
What this trial is testing

Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins

Who this might be right for
Cavernous Angioma, FamilialCerebral Cavernous MalformationsCerebral Cavernous Hemangioma
University of New Mexico 12
Not applicableStudy completedNCT00540566
What this trial is testing

Optical Biopsy of Human Skin in Conjunction With Laser Treatment

Who this might be right for
Malignant MelanomaMerkel Cell CarcinomaBasal Cell Carcinoma+12 more
University of California, Irvine 113
Testing effectiveness (Phase 2)Ended earlyNCT01266070
What this trial is testing

TKI 258 in Von Hippel-Lindau Syndrome (VHL)

Who this might be right for
Von Hippel-Lindau Syndrome
M.D. Anderson Cancer Center 6
Not applicableEnded earlyNCT05298709
What this trial is testing

Functional Magnetic Resonance Imaging (fMRI) Vascular Reactivity in Cerebral Cavernous Malformations (CCM)

Who this might be right for
Cerebral Cavernous Malformation
University of New Mexico 5
Not applicableLooking for participantsNCT06214767
What this trial is testing

Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations

Who this might be right for
Hemangioma, Cavernous, Central Nervous System
Beijing Tiantan Hospital 1,200
Testing effectiveness (Phase 2)Study completedNCT02603328
What this trial is testing

Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial

Who this might be right for
Cerebral Cavernous Malformation
University of Chicago 80
Testing effectiveness (Phase 2)WithdrawnNCT01408056
What this trial is testing

Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)

Who this might be right for
Infantile Hemangiomas
Children's Hospital of Philadelphia
Post-approval studies (Phase 4)Study completedNCT02625389
What this trial is testing

Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures

Who this might be right for
Congenital HemangiomaHemangioendotheliomaAngiosarcoma+1 more
Guerbet 132
Not applicableStudy completedNCT07327164
What this trial is testing

Precision Medicine for Neurocutaneous Syndromes in Western China

Who this might be right for
Neurocutaneous SyndromesNeurofibromatosis Type 1 (NF1)Tuberous Sclerosis Complex (TSC)+2 more
West China Hospital 1,200
Not applicableWithdrawnNCT04344626
What this trial is testing

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Who this might be right for
EpilepsyFocal Cortical DysplasiaTuberous Sclerosis+7 more
University of California, Los Angeles
Not applicableStudy completedNCT01764529
What this trial is testing

Modifiers of Disease Severity in Cerebral Cavernous Malformations

Who this might be right for
Cavernous Angioma, FamilialCerebral Cavernous MalformationsCerebral Cavernous Hemangioma
University of California, San Francisco 789
Testing effectiveness (Phase 2)Looking for participantsNCT06239272
What this trial is testing

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Who this might be right for
Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+39 more
St. Jude Children's Research Hospital 139
Testing effectiveness (Phase 2)Ended earlyNCT02110069
What this trial is testing

Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Who this might be right for
Kaposiform Hemangioendothelioma (KHE)Kasabach-Merritt SyndromeTufted Angioma
Boston Children's Hospital 4
Testing effectiveness (Phase 2)Study completedNCT00052013
What this trial is testing

Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584

Who this might be right for
Von Hippel-Lindau DiseaseCNS HemangioblastomaRetinal Hemangioblastoma
Novartis Pharmaceuticals 11
Testing effectiveness (Phase 2)Study completedNCT02859441
What this trial is testing

A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab

Who this might be right for
Von Hippel-Lindau Syndrome
National Eye Institute (NEI) 3
Not applicableStudy completedNCT00556946
What this trial is testing

Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains

Who this might be right for
Port Wine Stains
University of California, Irvine 17
Next Page